EAM
APRE icon

Erste Asset Management’s Aprea Therapeutics APRE Stock Holding History

Erste Asset Management’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,750
Closed -$177K – 500
2020
Q4 		$177K Hold
1,750
– – ﹤0.01% 441
2020
Q3 		$792K Hold
1,750
– – 0.03% 318
2020
Q2 		$1.28M Buy
1,750
+450
+35% +$295K 0.05% 275
2020
Q1 		$871K Buy
+1,300
New +$954K 0.05% 268

Other funds holding APRE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Erste Asset Management's APRE Position: Q1 2021 in Review

Erste Asset Management sold out of Aprea Therapeutics (APRE) in Q1 2021, closing a stake of 1,750 shares — an estimated $177K sold.

Erste Asset Management first reported a position in APRE in Q1 2020 and held it in 4 quarters. The position peaked at $1.28M in Q2 2020. 67 funds tracked by Wall St. Rank hold APRE as of Q1 2021.

  • Erste Asset Management reported no remaining Aprea Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Erste Asset Management sold 1,750 Aprea Therapeutics shares in Q1 2021, an estimated $177K.
  • Erste Asset Management first reported a position in Aprea Therapeutics in Q1 2020 and held it in 4 quarters.
  • Erste Asset Management's Aprea Therapeutics position peaked at $1.28M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.